Scholarly Index
Mark Nelson
University of Tasmania; 15,304 total citations; 453 total publications; best world rank #55
University of Tasmania
15,304Total citations
453Total publications
61H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Blood Pressure and Hypertension Studies | Lifetime | 660 | AU 36 | 98.14 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 847 | AU 28 | 96.53 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 375 | AU 23 | 93.30 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 960 | AU 32 | 92.77 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 185 | AU 9 | 96.00 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 286 | AU 12 | 95.43 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 600 | AU 65 | 95.06 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 282 | AU 8 | 93.87 |
| Chronic Disease Management Strategies | 2021-2025 | 334 | AU 17 | 91.57 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 55 | AU 3 | 87.16 |
| Inflammatory mediators and NSAID effects | 2021-2025 | 154 | AU 10 | 85.32 |
| Clinical practice guidelines implementation | 2021-2025 | 554 | AU 75 | 74.64 |
| Medication Adherence and Compliance | 2021-2025 | 689 | AU 45 | 73.99 |
| Health and Medical Research Impacts | 2021-2025 | 656 | AU 40 | 68.05 |
| Healthcare Systems and Practices | 2021-2025 | 706 | AU 24 | 68.21 |